Quick Answer
OptimizeRx Corp reported Net Income of $5.13 million for fiscal year 2025.
OptimizeRx Corp Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $5.13M | +125.5% |
| 2024 | -$20.11M | -14.5% |
| 2023 | -$17.57M | -53.6% |
| 2022 | -$11.44M | -3125.4% |
| 2021 | $378.1K | +117.1% |
| 2020 | -$2.21M | +29.8% |
| 2019 | -$3.14M | -1488.4% |
| 2018 | $226.3K | +110.8% |
| 2017 | -$2.10M | -36.7% |
| 2016 | -$1.54M | -158.6% |
| 2015 | -$595.1K | +42.0% |
| 2014 | -$1.03M | -283.6% |
| 2013 | -$267.3K | +41.2% |
| 2012 | -$454.6K | +78.6% |
| 2011 | -$2.12M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $779.0K | +108.5% | -49.2% |
| June 30, 2025 | $1.53M | +138.2% | +169.7% |
| March 31, 2025 | -$2.20M | +68.1% | +75.9% |
| September 30, 2024 | -$9.12M | -218.5% | -127.6% |
| June 30, 2024 | -$4.01M | +3.7% | +41.9% |
| March 31, 2024 | -$6.90M | -7.8% | -140.8% |
| September 30, 2023 | -$2.87M | +17.4% | +31.1% |
| June 30, 2023 | -$4.16M | -7.1% | +35.0% |
- OptimizeRx Corp showed an increase of +125.5% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, OptimizeRx Corp’s net income has grown by 342.0% (from -$2.12 million to $5.13 million).
- The most recent figure is from OptimizeRx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: